MedPage Today on MSN
Cemdisiran siRNA therapy demonstrates efficacy in myasthenia gravis
Investigational treatment improves outcomes without complete complement blockade ...
Emirates News Agency on MSN
Regulating immune protein C3 may slow ageing
WASHINGTON, 22nd April, 2026 (WAM) -- Researchers have found that slowing ageing may not be linked to dietary restriction as previously believed, but rather to regulating the activity of an immune ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
Abstract: Signal quality monitoring (SQM) technology has been proven to be effective in detecting spoofing attacks, with a simple structure and good feasibility. However, its detection performance ...
(MENAFN- GetNews) The Key Complement 3 Glomerulopathy Companies in the market include - NovelMed Therapeutics, Apellis Pharmaceuticals, Novartis, Amyndas Pharmaceuticals, and others. DelveInsight's ...
Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. Being a gamer all his life and enjoying everything from ARPGs like Diablo to JRPGs like Pokemon and Persona, ...
Early erythrolysis occurs within the hematoma following intracerebral hemorrhage (ICH), and the release of erythrocyte cytoplasmic proteins such as hemoglobin and Prx2 (peroxiredoxin 2) can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results